Clarus Lifesciences III, L.P.

Clarus Lifesciences III, L.P. is a declared insider at 9 companies; the most frequent names are Talaris Therapeutics, Inc., Praxis Precision Medicines, Inc. and Annexon, Inc. We count 53 filings; the first trade dates from 25 June 2018 and the latest from 30 March 2022.

Purchases make up the whole of the open-market record (13 purchases, €21.7M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €223k. 13 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 1 April 2022, the filings show a transaction in Imago BioSciences, Inc. The clock since the last published purchase (20 July 2021) now reads 1,938 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.